Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Licensing Models For New Markets - BIO Conference

This article was originally published in PharmAsia News

Executive Summary

CHICAGO - Whether or not the world is flat, licensing deals are no longer simply a transfer of global rights, and pharma companies are trying to determine how best to carve up regional rights and how to coordinate marketing efforts
Advertisement

Related Content

Kyowa Hakko Kirin, Ultragenyx To Develop Treatment For X-linked Hypophosphatemia
Japanese Products Can Find A Home In Emerging Markets With Partners Like Roche
Japanese Pharma, Hungry For Global Deals, Can Fill Gap of Shrinking Partners - PharmAsia Summit
Japanese Pharma, Hungry For Global Deals, Can Fill Gap of Shrinking Partners - PharmAsia Summit
Japanese Pharma, Hungry For Global Deals, Can Fill Gap Of Shrinking Partners - PharmAsia Summit
Japanese Pharma, Hungry For Global Deals, Can Fill Gap Of Shrinking Partners - PharmAsia Summit
Roche's Joe McCracken On Early-stage Partnering In Asia: An Interview With PharmAsia News (Part 2 Of 2)
Pfizer and Eisai Will Continue Aricept Deal, But Add Lyrica To The Agreement
Kyowa Hakko Kirin Licenses Anti-LIGHT MAB To Sanofi-Aventis
Kyowa Hakko Kirin Licenses Anti-LIGHT MAB To Sanofi-Aventis
Advertisement
UsernamePublicRestriction

Register

SC074784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel